Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Gentile

Showing results (31-40 of 276) with videos related to

Pageof 28
Sort By:
Hepatobiliary Surgery and Nutrition|June 9, 2020
SARS-CoV-2 and liver damage: a possible pathogenetic linkLudovico Abenavoli, Ivan Gentile, Alberto Enrico Maraolo, et al.
World Journal of Gastroenterology|September 25, 2012
Hepatitis B in pregnancyGuglielmo Borgia, Maria Aurora Carleo, Giovanni Battista Gaeta, et al.
New Microbes and New Infections|September 8, 2025
COVID-19 in immunocompromised patients: proposed definition of a new entity with prolonged infectionIvan Gentile, Nicola Schiano Moriello, Alberto Enrico Maraolo, et al.
Reviews on Recent Clinical Trials|April 9, 2020
Epidemiology of Coronavirus Disease Outbreak: The Italian TrendsLudovico Abenavoli, Pietro Cinaglia, Francesco Luzza, et al.
Expert Opinion on Drug Safety|September 3, 2015
Asunaprevir for hepatitis C: a safety evaluationIvan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, et al.
Expert Review of Anti-Infective Therapy|August 7, 2014
GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infectionIvan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Expert Opinion on Investigational Drugs|May 23, 2014
Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virusIvan Gentile, Nicola Coppola, Antonio Riccardo Buonomo, et al.
Expert Opinion on Investigational Drugs|December 17, 2009
The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virusIvan Gentile, Maria Aurora Carleo, Federico Borgia, et al.
European Journal of Internal Medicine|September 19, 2017
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stageIvan Gentile, Antonio Riccardo Buonomo, Riccardo Scotto, et al.
Expert Opinion on Pharmacotherapy|August 3, 2018
Current and emerging pharmacotherapy for the treatment of bacterial peritonitisAlberto Enrico Maraolo, Ivan Gentile, Biagio Pinchera, et al.
Pageof 28

Showing results (31-40 of 276) with videos related to

Sort By:
Pageof 28
Hepatobiliary Surgery and Nutrition|June 9, 2020
SARS-CoV-2 and liver damage: a possible pathogenetic linkLudovico Abenavoli, Ivan Gentile, Alberto Enrico Maraolo, et al.
World Journal of Gastroenterology|September 25, 2012
Hepatitis B in pregnancyGuglielmo Borgia, Maria Aurora Carleo, Giovanni Battista Gaeta, et al.
New Microbes and New Infections|September 8, 2025
COVID-19 in immunocompromised patients: proposed definition of a new entity with prolonged infectionIvan Gentile, Nicola Schiano Moriello, Alberto Enrico Maraolo, et al.
Reviews on Recent Clinical Trials|April 9, 2020
Epidemiology of Coronavirus Disease Outbreak: The Italian TrendsLudovico Abenavoli, Pietro Cinaglia, Francesco Luzza, et al.
Expert Opinion on Drug Safety|September 3, 2015
Asunaprevir for hepatitis C: a safety evaluationIvan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, et al.
Expert Review of Anti-Infective Therapy|August 7, 2014
GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infectionIvan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Expert Opinion on Investigational Drugs|May 23, 2014
Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virusIvan Gentile, Nicola Coppola, Antonio Riccardo Buonomo, et al.
Expert Opinion on Investigational Drugs|December 17, 2009
The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virusIvan Gentile, Maria Aurora Carleo, Federico Borgia, et al.
European Journal of Internal Medicine|September 19, 2017
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stageIvan Gentile, Antonio Riccardo Buonomo, Riccardo Scotto, et al.
Expert Opinion on Pharmacotherapy|August 3, 2018
Current and emerging pharmacotherapy for the treatment of bacterial peritonitisAlberto Enrico Maraolo, Ivan Gentile, Biagio Pinchera, et al.
Pageof 28